The use of imatinib for chronic myeloid leukaemia
Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS))
Record ID 32005000607
English
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/guidance/TA50
Year Published:
2002
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Magnetic Resonance Imaging
- Leukemia, Myeloid, Chronic-Phase
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemic Infiltration
Contact
Organisation Name:
Health Technology Board for Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS)) (HTBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.